Overview

* Kits Eyecare ( KTYCF ) Q3 revenue rises 25.1% yr/yr to all-time high of C$52.4 mln

* Adjusted EBITDA for Q3 improves 79% to C$2.9 mln

* Net income for Q3 surges to C$1.9 mln, up 1,367.4% yr/yr

Outlook

* Kits Eyecare expects Q4 2025 revenue between C$52 mln and C$54 mln

* Company anticipates Q4 2025 adjusted EBITDA margin between 4% and 6%

* Kits Eyecare plans to announce a Chief Marketing Officer in Q1 2026

Result Drivers

* STRATEGIC PRICING - Margin expansion driven by strategic pricing, improved product mix, and targeted promotions

* CUSTOMER GROWTH - Active customers surpassed 1 million, increasing 15.7% yr/yr

* DISCIPLINED EXECUTION - Profitability driven by disciplined execution in pricing, marketing, and fulfillment

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 EPS C$0.06

Q3 Net C$1.90

Income mln

Q3 C$3.30

EBITDA mln

Q3 Gross C$18.10

Profit mln

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the miscellaneous specialty retailers peer group is "buy"

* Wall Street's median 12-month price target for Kits Eyecare Ltd ( KTYCF ) is C$23.00, about 42.7% above its November 5 closing price of C$13.18

* The stock recently traded at 47 times the next 12-month earnings vs. a P/E of 72 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)